Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/27/2003WO2003097818A1 A method for producing transgenic animal mammary glands secreting human erythropoietin (epo).
11/27/2003WO2003097816A1 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith
11/27/2003WO2003097815A2 Molecular identification of aspergillus species
11/27/2003WO2003097812A2 Transgenic ungulates capable of human antibody production
11/27/2003WO2003097811A2 Cellular gene targets for controlling cell growth
11/27/2003WO2003097808A2 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence
11/27/2003WO2003097805A2 Delivery of nucleic acid-like compounds
11/27/2003WO2003097798A2 Carotene synthase gene and uses therefor
11/27/2003WO2003097797A2 Methods of adenovirus purification
11/27/2003WO2003097796A2 T7 bacteriophage display of fabs
11/27/2003WO2003097795A2 Constitutively translocating cell line
11/27/2003WO2003097791A2 Polynucleotide sequences encoding alkaline a-galactosidases and methods of using same
11/27/2003WO2003097790A2 Genes and uses thereof to modulate secondary metabolite biosynthesis
11/27/2003WO2003097786A1 Conductive microplate
11/27/2003WO2003097688A2 Muteins of placental growth factor type 1, preparation method and application thereof
11/27/2003WO2003097686A1 Novel protein, its dna and use thereof
11/27/2003WO2003097685A1 Clarin polypeptides, polynucleotides encoding same and uses thereof in diagnosis and treatment of usher's syndrome
11/27/2003WO2003097680A2 Anti-bacterial peptides, genes coding for peptides, transformed organisms, vectors, preparation thereof and compositions containing same
11/27/2003WO2003097678A2 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum
11/27/2003WO2003097677A2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
11/27/2003WO2003097676A1 Polypeptide antigen inducing hiv neutralizing antibodies
11/27/2003WO2003097675A1 Fusion protein of hiv regulatory/accessory proteins
11/27/2003WO2003097674A1 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
11/27/2003WO2003097673A2 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles.
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097662A1 Antisense modulation of apolipoprotein b expression
11/27/2003WO2003097661A2 Antiviral phosphorothioate oligonucleotides
11/27/2003WO2003097239A1 Sample carrier having releasable locking mechanism
11/27/2003WO2003097158A2 Electroporation-mediated transfection of the salivary gland
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097090A1 Use of modified novirhabdoviruses to obtain vaccines
11/27/2003WO2003097089A2 Attenuation of metapneumovirus
11/27/2003WO2003096981A2 Method of modulating angiogenesis
11/27/2003WO2003096974A2 ORIENTIA TSUTSUGAMUSHI TRUNCATED RECOMBINANT OUTER MENBRANE PROTEIN (r47) AND (r56) VACCINES DIAGNOSTICS AND THERAPEUTICS FOR SCRUB TYPHUS AND HIV INFECTION
11/27/2003WO2003096969A2 Novel lambda phage display system and the process
11/27/2003WO2003096869A2 Recombinant bet. v. 1. allergen mutants, methods and process thereof
11/27/2003WO2003096808A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis
11/27/2003WO2003096804A1 Heparin-binding epidermal growth factor-like growth factor gene-modified animal, screening method, embryonic stem cells and preventive and/or remediy for heart failure
11/27/2003WO2003096797A2 Method of increasing plant organ and seed size in a plant
11/27/2003WO2003085087A3 Modified cea nucleic acid and expression vectors
11/27/2003WO2003083096A3 Cancer associated protein kinases and their uses
11/27/2003WO2003080828A3 Nucleic acid molecules involved in the synthesis of melithiazols
11/27/2003WO2003080638A9 Antisense iap nucleobase oligomers and uses thereof
11/27/2003WO2003080570A3 Recombinant expression vectors for functional nav1.9 sodium channels
11/27/2003WO2003078613A3 Serine hydroxymethyltransferase as a target for herbicides
11/27/2003WO2003078589A3 Method of identifying genes controlling diferentiation
11/27/2003WO2003078580A3 Imprinting in plants to control gene expression
11/27/2003WO2003078568A3 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
11/27/2003WO2003076598A3 Method of inducing an enhanced immune response against hiv
11/27/2003WO2003076563A3 Human protooncogene and protein encoded therein
11/27/2003WO2003076469A3 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
11/27/2003WO2003075841A3 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
11/27/2003WO2003075669A3 Food fermentation with lactic acid bacteria
11/27/2003WO2003073980A3 Recombinant protein c variants
11/27/2003WO2003072828A3 Fcgammariib polymorphisms detection in system lupus erythematosus
11/27/2003WO2003072594A3 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
11/27/2003WO2003072045A3 Treatment and prevention of aids progression and methods of using same
11/27/2003WO2003070931A3 Methods for conducting site-specific dna recombination
11/27/2003WO2003070765A3 Growth hormone fusion protein
11/27/2003WO2003068802A3 Materials and methods for preparing dimeric growth factors
11/27/2003WO2003067209A3 Ligands to enhance cellular uptake of biomolecules
11/27/2003WO2003066661A3 Human dr4 antibodies and uses thereof
11/27/2003WO2003064691A3 Methods and means for amplifying nucleic acid
11/27/2003WO2003064622A3 Aggrecanase molecules
11/27/2003WO2003064604A3 Translation profiling
11/27/2003WO2003062434A3 Transgenic tea plants obtained through microprojectile bombardment of leaf explants
11/27/2003WO2003062378A3 Methods of random mutagenesis and methods of modifying nucleic acids using translesion dna polymerases
11/27/2003WO2003062270A3 Fluorescent protein from aequorea coerulscens and uses therof
11/27/2003WO2003062268A3 Corticotropin releasing factor receptor 2 agonists
11/27/2003WO2003057897A3 Recombinant protein expression
11/27/2003WO2003057837A3 Methods for using anti-muc18 antibodies
11/27/2003WO2003056020A3 Expression vectors and promoters for heterologous gene expression
11/27/2003WO2003055505A3 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
11/27/2003WO2003054004A3 Secreted proteins
11/27/2003WO2003053338A3 Novel chimeric rev, tat, and nef antigens
11/27/2003WO2003052083A3 Methods for the generation of proliferating and differentiating cell lines
11/27/2003WO2003051901A3 Pseudonucleotide comprising an intercalator
11/27/2003WO2003051383A3 Use of hmgb proteins and nucleic acids that code therefor
11/27/2003WO2003050252A3 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
11/27/2003WO2003048368A3 Plants having altered abscisic acid (aba) sensitivity
11/27/2003WO2003048178A3 Nucleotide analogues and their use for nucleic acid sequencing
11/27/2003WO2003046212A3 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells
11/27/2003WO2003046176A3 Protein-protein interactions in human immunodeficiency virus
11/27/2003WO2003046150A3 Glycoprotein remodeling using endoglycanases
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003043986A3 Polypeptides of moraxella (branhamella) catarrhalis
11/27/2003WO2003042344A3 Apo2 ligand/trail formulations
11/27/2003WO2003042249A3 Peptide purification by means of metal ion affinity chromatography
11/27/2003WO2003040299A3 Method of selecting hla-dp4 ligands and the applications thereof
11/27/2003WO2003038099A3 Regulation of gene transcription by the variable number of tandem repeats (vntr) domain of the dopamine transporter gene
11/27/2003WO2003037932A3 Human coagulation factor vii polypeptides
11/27/2003WO2003035883A3 Methods and compositions for inducing tumor-specific cytotoxicity
11/27/2003WO2003035696A3 Humanized antibodies against icam-1, their production and uses
11/27/2003WO2003034275A3 Chimeric glycosylphosphatidylinositol containing peptides
11/27/2003WO2003031578A3 Mammalian c-type lectins
11/27/2003WO2003031573A3 Toll-like receptor 3 signaling agonists and antagonists
11/27/2003WO2003030832A3 Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer
11/27/2003WO2003030824A3 Methods and compositions for treating dermal lesions
11/27/2003WO2003029464A3 Genes associated with mast cell activation
11/27/2003WO2003029463A3 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
1 ... 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 ... 4023